Zoledronic acid beneficial in patients with bone metastases

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1292, 2001-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zoledronic acid, pamidronic acid on equal footing in bone metastases

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 475, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Zoledronic acid, pamidronic acid on equal footing in bone metastases

Inpharma, Vol. 1, Iss. 1485, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Zoledronic Acid: A Review of its Use in the Management of Bone Metastases of Malignancy

By Dhillon Sohita Lyseng-Williamson Katherine A.

Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. : 507-534

Adis International

Access to resources Recommend Favorite

Zoledronic Acid: A Pharmacoeconomic Review of its Use in the Management of Bone Metastases

By McKeage Kate Plosker Greg L.

PharmacoEconomics, Vol. 26, Iss. 3, 2008-01 ,pp. : 251-268

Adis International

Access to resources Recommend Favorite

Zoledronic Acid: A Review of its Use in the Management of Bone Metastases and Hypercalcaemia of Malignancy

By Wellington K. Goa K.L.

Drugs, Vol. 63, Iss. 4, 2003-01 ,pp. : 417-437

Adis International

Access to resources Recommend Favorite